0001171843-15-004863.txt : 20150824
0001171843-15-004863.hdr.sgml : 20150824
20150824163425
ACCESSION NUMBER: 0001171843-15-004863
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150820
FILED AS OF DATE: 20150824
DATE AS OF CHANGE: 20150824
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: IMMUNOMEDICS INC
CENTRAL INDEX KEY: 0000722830
STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
IRS NUMBER: 611009366
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0630
BUSINESS ADDRESS:
STREET 1: 300 AMERICAN RD
CITY: MORRIS PLAINS
STATE: NJ
ZIP: 07950
BUSINESS PHONE: 9736058200
MAIL ADDRESS:
STREET 1: 300 AMERICAN ROAD
CITY: MORRIS PLAINS
STATE: NJ
ZIP: 07950
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: GOLDENBERG CYNTHIA L
CENTRAL INDEX KEY: 0001202016
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-12104
FILM NUMBER: 151071334
MAIL ADDRESS:
STREET 1: C/O XIMMUNOMEDICS INC
STREET 2: 300 AMERICAN RD
CITY: MORRIS PLAINS
STATE: NJ
ZIP: 07950
FORMER NAME:
FORMER CONFORMED NAME: SULLIVAN CYNTHIA L
DATE OF NAME CHANGE: 20021029
4
1
formfour.xml
X0306
4
2015-08-20
0
0000722830
IMMUNOMEDICS INC
IMMU
0001202016
GOLDENBERG CYNTHIA L
C/O IMMUNOMEDICS, INC.
300 THE AMERICAN ROAD
MORRIS PLAINS
NJ
07950
1
1
0
0
President and CEO
Common Stock
2015-08-20
4
A
0
198864
0
A
759873
D
Common Stock
5398127
I
See footnote.
Stock Option (right to buy)
1.76
2015-08-20
4
A
0
408163
A
2022-08-20
Common Stock, par value $0.01 per share
408163
408163
D
Such restricted stock units were granted pursuant to the Immunomedics, Inc. 2014 Long-Term Incentive Plan, and vest 25% on the first anniversary of the date of grant and 6.25% on a quarterly basis thereafter.
Includes a total of 190,000 shares held as joint tenants by the reporting person and her spouse, David M. Goldenberg, the Issuer's Chief Scientific Officer, Chief Patent Officer, and Chairman of the Board of Directors.
Such shares are held by the reporting person's spouse, by various trusts established for the benefit of the reporting person and/or family members of the reporting person, or by a majority-owned subsidiary of the Issuer, of which the reporting person is an officer. The reporting person disclaims beneficial ownership of these shares except to the extent of her pecuniary interests therein.
Such stock options were granted pursuant to the Immunomedics, Inc. 2014 Long-Term Incentive Plan, and vest 25% on the first anniversary of the date of grant and 6.25% on a quarterly basis thereafter.
/s/ Cynthia L. Goldenberg
2015-08-24